SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-08-005190
Filing Date
2008-04-25
Accepted
2008-04-25 09:10:10
Documents
5
Period of Report
2008-05-30
Effectiveness Date
2008-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2184871zdef14a.htm DEF 14A 518618
2 G917356.JPG g917356.jpg GRAPHIC 1554
3 G90414.JPG g90414.jpg GRAPHIC 3548
4 G836232.JPG g836232.jpg GRAPHIC 3900
5 G921954.JPG g921954.jpg GRAPHIC 14719
  Complete submission text file 0001047469-08-005190.txt   553332
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19700 | Film No.: 08775997
SIC: 2834 Pharmaceutical Preparations